Netherlands· NL-6b9224ddc82f
Parlodel 2,5 mg, tabletten
A bromocriptine product containing bromocriptinemesilaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 9 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Bromocriptine is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB01 (bromocriptine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Bromocriptine · ATC G02CB01
9 / 19 countries
- Czechiaprice
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of bromocriptine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.54 in Italy to $3.22 in United States — a ×5.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Bromocriptine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- US United States$3.22 (acquisition cost)
- CH Switzerland$2.09
- IT Italy$0.54
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BROMOCRIPTINEMESILAAT
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- G02CB01
- ATC class
- Bromocriptine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id135732//08202
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for bromocriptine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromocriptine · interactions on record
92 records
- 3 severe
- 87 moderate
- 2 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- LansoprazoleA02BC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 2.5mg tabletsTeva UK Ltd
- United StatesBromocriptine mesylateREMEDYREPACK INC.
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- SwedenParlodel 2,5 mg Tablett2care4 ApS
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
- NorwayParlodelMeda
- SwitzerlandParlodel, TablettenSandoz Pharmaceuticals AG
- FinlandParlodelParanova Oy
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b90579af-ffe3-47a5-a388-7788e9efd61e GET /v1/drugs/b90579af-ffe3-47a5-a388-7788e9efd61e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h08202_smpc.pdf",
"strength": null,
"atc_label": "Bromocriptine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135732",
"excipients": [
"DINATRIUMEDETAAT 2-WATER",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MALEÏNEZUUR",
"MAÏSZETMEEL",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"BROMOCRIPTINEMESILAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135732.pdf",
"authorised_at": "2026/01/07",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "135732//08202",
"additional_monitoring": "N"
}See everything about bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.